In comeback bid, Shkreli’s old company gets OK to buy life-saving drug
Ars Technica » Scientific Method 2016-02-27
Summary:
Amid outcry, KaloBios may jack the drug's price and make millions off FDA voucher.
Link:
http://arstechnica.com/science/2016/02/in-comeback-bid-shkrelis-old-company-gets-ok-to-buy-life-saving-drug/From feeds:
Cyberlaw » Ars TechnicaMusic and Digital Media » Ars Technica
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method